Cyanide-bridged Fe(III)–Co(II) bis double zigzag chains with a slow relaxation of the magnetisation

Reaction of [FeIII(bipy)(CN)4]¯ with fully solvated MII cations [M = Co (1) and Mn (2)] produces the isostructural bis double zigzag chains [[FeIII(bipy)(CN)4]2MII(H2O)]·MeCN·1/2H2O; 1 exhibits intrachain ferromagnetic and interchain antiferromagnetic couplings, slow magnetic relaxation and hysteresis effects.Luminita Marilena, Toma, [email protected] ; Lescouezec, Alain Francois Rodri, [email protected] ; Lloret Pastor, Francisco, [email protected] ; Julve Olcina, Miguel, [email protected]

The azido ligand: a useful tool in designing chain compounds exhibiting alternating ferro- and antiferro-magnetic interactions

A one-pot reaction of NiII 1, CoII 2, FeII 3 and MnII 4 with 2,2A-bipyridine (bipy) and azide in water leads to [M(bipy)(N3)2]n chains where the metal ion is alternatively bridged by double end-on (EO) and end-to-end (EE) azido bridges; theoretical analysis of the variable-temperature magnetic susceptibility data of 1 and 4 reveals the occurrence of intrachain alternating ferro- (through EO) and antiferro-magnetic (through EE) interactions.Julve Olcina, Miguel, [email protected] ; Lloret Pastor, Francisco, [email protected] ; Clemente Juan, Juan Modesto, [email protected]

Click synthesis, anticancer activity, and molecular docking investigation of some functional 1,2,3-triazole derivatives

1,2,3-triazole skeleton is a privileged building block for the discovery of new promising anticancer agents. In this report, new 1,4-disubstituted 1,2,3-triazoles with the bioisoster triazole moiety were straightforwardly prepared under copper-catalyzed azide-alkyne [3+2] cycloaddition reactions (CuAAC) regime using a variety of both functional organic azides and terminal alkynes. The resulting functional 1,4-disubstituted 1,2,3-triazole compounds were fully characterized and subsequently tested for their antiproliferative activity against four different cancer cell lines. The cytotoxicity tests carried out with these 1,2,3-triazole derivatives show average IC50 values ranging from 15 to 50 μM by comparison with the standard reference drug, namely doxorubicin. The phosphonate 1,2,3-triazole derivative was found to exhibit the best antiproliferative activity among the studied compounds against the HT-1080 cell lines. It was chosen to evaluate its mode of action in these cancer cell lines. The cell cycle study showed that the phosphonate derivative, compound 8, is the most active inhibitor of the cell cycle at the G0/G1 phase, inducing apoptosis independently of Caspase-3 and causing an increase in the mitochondrial membrane potential (ΔΨm) in the HT-1080 cell lines. Molecular docking studies of this phosphonate derivative into the MMP-2 and MMP-9 metalloproteinases receptors demonstrated the relevance of triazole scaffolds and the pendant phosphonate group in establishing -anion, -alkyl and hydrogen bonding type interactions with residual components in the active MMP pocket